News & Analysis as of

Private Equity Innovation Acquisitions

MoFo Life Sciences

Key Developments in MedTech M&A: Momentum Despite Macroeconomic Uncertainty

MoFo Life Sciences on

2024 was a challenging year for M&A activity in the medical technology (“MedTech”) industry. Although some sectors experienced a rebound in deal volume, MedTech dealmakers were disproportionately affected by a difficult...more

Skadden, Arps, Slate, Meagher & Flom LLP

Europe’s Sharpened Focus on Defense Creates M&A and Investment Opportunities

Key Points - - The war in Ukraine has prompted a historic surge in European defense spending. - Governments in the EU and U.K. are stressing the need for innovation. They are increasingly turning to investment in small...more

Mintz

Demystifying PE-Backed Boards: Opportunity, Risk, and the Evolving Role of Directors

Mintz on

Private equity boards often carry a certain mystique — and, let’s face it, a bit of stigma. Many directors react to the idea with hesitancy, imagining high pressure, constant turnover, and limited governance influence. But as...more

Davis Wright Tremaine LLP

Food Venture Financing News - Weekly Issue No. 239

Food Venture Financing - Trends David, a protein bar emerging brand, announced that it raised $75 million in its Series A round....more

Morgan Lewis

M&A Considerations Across the Technology Sector

Morgan Lewis on

Technology is quickly becoming one of the most active and dynamic sectors for mergers and acquisitions (M&A) in 2025. Despite a macro environment filled with uncertainty, technology deal activity reflects an appetite for...more

Foley & Lardner LLP

Why Korea Is Gaining Prominence for M&A Activity

Foley & Lardner LLP on

Korea, known for its rich culinary heritage, fascinating history, and renowned hospitality, has long rendered Seoul a favored travel destination. Today, it stands not only as a cultural and historical beacon but also as a...more

McDermott Will & Emery

Pharma and MedTech Services Investment Summit 2024

McDermott Will & Emery on

The inaugural Pharma and MedTech Services Investment Summit brought together C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

McDermott Will & Emery

[Event] Pharma and MedTech Services Investment Summit 2024 - May 2nd, San Francisco, CA

McDermott Will & Emery on

YOUR SOURCE FOR SUCCESS IN PHARMA AND DEVICE SERVICES INVESTING - Join C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

Benesch

Benesch DSO Market Intelligence Bi-Monthly Report: March - May 2022

Benesch on

Dentists continue to shift toward DSO-supported practices amid ongoing labor challenges - According to the American Dental Association, DSO-supported practices are now considered one of the fastest growing practice models...more

McDermott Will & Emery

[Virtual Event] 2021 J.P. Morgan Healthcare Conference - Life Sciences Investment Forum - January 11th, 10:00 am - 1:00 pm EST

You won’t want to miss four days of exclusive, virtual events that bring together industry leaders, emerging standouts, innovators and investors from across the industry landscape at the largest healthcare investment...more

Hogan Lovells

Life Sciences and Health Care Horizons - 2018

Hogan Lovells on

Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more

11 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide